glp-1 agonist review Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping GLP-1 receptor agonists | How
Description
GLP-1 access without insurance is achievable through compounded medications, patient assistance programs, and direct-to-patient models
95% CI: 0.581.14)
Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for these drugs.
Lilly have launched a Trulicity (dulaglutide), a once-weekly injectable to improve glycaemic control in adults with type II diabetes.
SUMMARYIncretin therapy is based on the antidiabetic actions of the incretin hormone GLP-1
